ABUS
Arbutus Biopharma Corporation
Set alert
4.21 USD -0.07 -1.64%
4.14 Day range 4.30
3.67 52-week range 5.22
- YTD
- -12.47%
- 1 year
- -13.02%
- Open
- 4.28
- Prev close
- 4.28
- Mkt cap
- 645.29M
- Vol
- 2.53M
- Avg vol
- 4.88M
- EPS
- 0.79
- P/E
- 5.33
- Div yield
- 0.00%
More statistics
- Low
- 4.14
- High
- 4.30
- Forward P/E
- -30.67
- Beta
- 0.62
- Short ratio
- 5.03
- Inst. own
- 72.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 4.79
- 200-d avg
- 4.52
- 1y target
- 5.46
1Y chart
Closing price and volume
Compare ABUS
Chart and line up ABUS against other symbols or a saved comparison set.
- ABUS Arbutus Biopharma Corporation
4.21
-0.07 -1.64%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | ABUS | SPY | QQQ |
|---|---|---|---|
| Last price | 4.21 | 755.72 | 690.49 |
| Change | -0.07 | -13.64 | -24.85 |
| Change % | -1.64% | -1.77% | -3.47% |
| Open | 4.28 | 761.38 | 697.13 |
| Day high | 4.30 | 761.46 | 698.63 |
| Day low | 4.14 | 750.36 | 683.45 |
| Previous close | 4.28 | 769.36 | 715.34 |
| Volume | 2.53M | 77.70M | 85.24M |
| Average volume | 4.88M | 41.22M | 34.57M |
| Market cap | 645.29M | 812.08B | 483.28B |
| P/E ratio | 5.33 | 23.99 | 26.44 |
| Earnings per share | 0.79 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 5.22 | 779.09 | 759.66 |
| 52-week low | 3.67 | 631.97 | 558.28 |
| 1-week return | +0.238095% | -0.559233% | -1.97% |
| 1-month return | -11.92% | -0.906075% | -6.66% |
| 3-month return | -4.54% | +1.89% | +1.02% |
| 6-month return | +0.238095% | +5.16% | +3.41% |
| Year-to-date return | -12.47% | +10.82% | +12.40% |
| 1-year return | -13.02% | +11.16% | +10.29% |
| 2-year return | +9.35% | +32.90% | +42.71% |
| 50-day moving average | 4.72 | 767.63 | 725.41 |
| 200-day moving average | 4.50 | 728.53 | 679.17 |
| Target price | 5.46 | — | — |
| Beta | 0.622 | 0.00 | 0.00 |
| Short ratio | 5.03 | — | — |
| Institutional ownership | 72.71% | — | — |